Fresenius Kabi USA LLC - Strategic SWOT Analysis Review

GlobalData
27 Pages - GLDATA60787
$125.00

Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable and specialty pharmaceutical products, transfusion technologies, parenteral nutrition and enteral nutrition. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Fresenius Kabi USA LLC Key Recent Developments

Aug 18, 2016: Fresenius Kabi Launches Smoflipid in the United States
Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Fresenius Kabi USA LLC - Key Facts 5
Fresenius Kabi USA LLC - Key Employees 6
Fresenius Kabi USA LLC - Key Employee Biographies 7
Fresenius Kabi USA LLC - Major Products and Services 8
Fresenius Kabi USA LLC - History 10
Fresenius Kabi USA LLC - Company Statement 14
Fresenius Kabi USA LLC - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Fresenius Kabi USA LLC - Business Description 16
Fresenius Kabi USA LLC - SWOT Analysis 17
SWOT Analysis - Overview 17
Fresenius Kabi USA LLC - Strengths 17
Fresenius Kabi USA LLC - Weaknesses 18
Fresenius Kabi USA LLC - Opportunities 19
Fresenius Kabi USA LLC - Threats 20
Fresenius Kabi USA LLC - Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Fresenius Kabi USA LLC, Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Aug 18, 2016: Fresenius Kabi Launches Smoflipid in the United States 25
Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 26
Section 5 – Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Fresenius Kabi USA LLC, Key Facts 5
Fresenius Kabi USA LLC, Key Employees 6
Fresenius Kabi USA LLC, Key Employee Biographies 7
Fresenius Kabi USA LLC, Major Products and Services 8
Fresenius Kabi USA LLC, History 10
Fresenius Kabi USA LLC, Other Locations 15
Fresenius Kabi USA LLC, Subsidiaries 15
Fresenius Kabi USA LLC, Key Competitors 21
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Fresenius Kabi USA LLC, Recent Deals Summary 24

List of Figures
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 23

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838